Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Open-label extension of RIN-PH-302.
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| inhaled treprostinil | Experimental |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| inhaled treprostinil | Drug | 0.6mg/mL inhalation solution, up to 12 breaths four times a day |
|
| Measure | Description | Time Frame |
|---|---|---|
| Long term safety of inhaled treprostinil | up to 5 years |
| Measure | Description | Time Frame |
|---|---|---|
| Six-minute walk distance | up to 5 years |
Not provided
Participation and completion of all required visits for study RIN-PH-302.
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| ID | Term |
|---|---|
| D000081029 | Pulmonary Arterial Hypertension |
| ID | Term |
|---|---|
| D006976 | Hypertension, Pulmonary |
| D008171 | Lung Diseases |
| D012140 | Respiratory Tract Diseases |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided